In the diabetes study, SBP decreased by up to 8.8mmHg with retatrutide versus a reduction of 1.5mmHg with dulaglutide, and an increase of 1.5mmHg with placebo [4]
Acuda urgentemente al mdico si tiene dificultad para respirar, hinchazn de la cara o la garganta, dolor abdominal intenso que no remite o sntomas que aparezcan de forma repentina y parezcan graves
All three brands contain the same active ingredient, semaglutide, but serve different purposes
Common Side Effects Nausea (most common, peaks during dose escalation) Diarrhea, constipation, vomiting Decreased appetite, fatigue, headache Injection-site reactions (injectable forms) Rare: pancreatitis, gallbladder disease, kidney injury FDA boxed warning for medullary thyroid carcinoma (do not use with personal or family history of MTC or MEN2) How to Start GLP-1 Treatment See a clinician in-person primary care, endocrinology, obesity medicine, or US telehealth
Working with an experienced medical team makes the difference between getting good results and getting lasting results